Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024: USD -40.13 M

Inspire Medical Systems, Inc. Capital Expenditure is USD -40.13 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -116.38% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Inspire Medical Systems, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -18.55 M, a -177.68% change year over year.
  • Inspire Medical Systems, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -6.68 M, a -40.94% change year over year.
  • Inspire Medical Systems, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -4.74 M, a -106.67% change year over year.
  • Inspire Medical Systems, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -2.29 M, a 7.84% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
NYSE: INSP

Inspire Medical Systems, Inc.

CEO Mr. Timothy P. Herbert
IPO Date May 3, 2018
Location United States
Headquarters 5500 Wayzata Boulevard
Employees 1,011
Sector Health Care
Industries
Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Similar companies

OM

Outset Medical, Inc.

USD 0.81

0.53%

PODD

Insulet Corporation

USD 267.04

-0.35%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

GMED

Globus Medical, Inc.

USD 88.18

1.15%

INMD

InMode Ltd.

USD 16.07

0.63%

DXCM

DexCom, Inc.

USD 79.17

-0.84%

TNDM

Tandem Diabetes Care, Inc.

USD 35.79

-1.16%

NARI

Inari Medical, Inc.

USD 79.30

-0.05%

PEN

Penumbra, Inc.

USD 252.89

2.41%

NVCR

NovoCure Limited

USD 26.23

-4.20%

CLPT

ClearPoint Neuro, Inc.

USD 14.70

-4.54%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

StockViz Staff

January 15, 2025

Any question? Send us an email